Today at Berkeley Lab

Modified Antibody Clarifies Tumor-Killing Mechanisms

At the Advanced Light Source, researchers studied an antibody that was modified to activate a specific pathway of the immune system, demonstrating its value in killing tumor cells. The work provides a platform for disentangling the effects of different immune-system pathways and could lead to the design of improved cancer immunotherapies. More>

You can leave a comment. View the Comment Policy.

Leave a Reply